Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    4%
    Check dated 2025-10-06T05:23:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed several important MedlinePlus topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) and added a new version tag (v3.1.0).
    Difference
    0.7%
    Check dated 2025-09-29T03:03:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new Publications entry referencing a recent PubMed article on empagliflozin and beta-cell preservation in women with recent gestational diabetes; no deletions were made.
    Difference
    4%
    Check dated 2025-09-21T22:37:29.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; a 'Back to Top' UI element was removed (minor UI change).
    Difference
    0.3%
    Check dated 2025-09-14T19:10:53.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T15:21:58.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to drug safety and counterfeit drugs. Notably, the previous version's details on empagliflozin and various pharmacological terms have been removed.
    Difference
    5%
    Check dated 2025-08-31T11:50:58.000Z thumbnail image

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.